About the Journal

Focus and Scope

CAS Medicine is a bilingual and open access journal that offers a rapid path to publishing medicine- and health-related articles.  

CAS Medicine focuses on publishing the latest and influential research findings in various areas of clinical practice, translational medicine, public health, health policy as well as the current topics that are of great interest to the clinician and biomedical researcher communities. The journal will also consider fundamental research that has great potential in being translated into clinical applications.

Current areas of interest also include, but are not limited to:

  • Latest advances in molecular and translational medicine that provide novel mechanistic insights into pathogenesis and development of a variety of diseases
  • Development of new diagnostic tests and methodologies (including biomarker studies)
  • Latest findings from clinical trials
  • New molecules and compounds that have high therapeutic potentials and their mechanisms of action
  • Advances in the current treatments of diseases and reviews on the emerging therapeutic strategies
  • Implications of latest research findings, new diagnostic and therapeutic strategies as well as policies on clinical care and practice
  • Challenges and opportunities in improving health care


Section Policies


In this category, we generally consider the submissions of original articles, reviews, perspectives, and case reports for publication in CAS Medicine. The editor will contact the corresponding author if submission is not suitable for publication in CAS Medicine.

There is no limit with regards to word count and section style. It is important that the authors read and adhere to the Author Guidelines prior to making submissions to this category.


Secondary Publications

Considering the need to disseminate important information to the widest possible audience, Secondary Publications of materials published in other journals or venues can be published in CAS Medicine.

Authors who seek for secondary publications in CAS Medicine of their original publications must obtain approval from original publisher and copyright owner before submission. The secondary version should faithfully reflect the original authors, data, and interpretations of the primary version. Secondary version can be in a language different from the original version’s, but only English or Chinese is allowed in CAS Medicine. If necessary, authors may have the original version translated to either English or Chinese before submission.

Ideally, the authors should appropriately cite the original version in the secondary version.


Publication Frequency



Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.



CAS Medicine is a bilingual journal. All articles can be written in either English or Chinese.

The manuscript must be presented in an intelligible fashion (good readability, clarity and logical flow considered) and is written in standard English or Chinese. CAS Medicine reserves the right to reject or desk-reject submissions that do not meet these standards.

American English is preferred if articles are written in English, but no mixture of different English variants (e.g. American English and British English) is allowed. If you are not a native English speaker, you may want to utilize an external or Inno Science Press’s optional professional language editing service (contact us at editorial@innosciencepress.com) before submitting the manuscript. Please note that utilizing a language editing service is not a guarantee of acceptance.


Editorial Policies

Authors should read the “Author Guidelines” before making a submission, and make sure that the manuscripts were written in accordance with the style and specifications of the journal’s policy.

All manuscripts will be treated as confidential materials. The manuscripts will not be disclosed to anyone except individuals such as editorial staff and editors who participate in the initial screening, review, processing and preparation of the manuscript for publication (if accepted).


Publishing Ethics

The journal editors take all possible misconducts seriously. The Editors, authors or readers can forward their concerns to the journal if they find out that the description in a submitted article may constitute an academic fraud, research misconduct or publication malpractice. The concerns or complaints on the possible allegations submitted to the journal will be dealt with appropriately. The complainant may direct all inquiries and correspondence to the Publisher at editorial@innosciencepress.com.



The editorial team does not approve of any plagiarism attempts. iThenticate will be utilized at the editor’s discretion to verify the originality of submitted manuscripts. If plagiarism is detected during the review process, the manuscript may be rejected depending on the severity of plagiarism.

If a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited.



Authorship should be limited to people who have contributed substantially to the work. Authors must indicate their specific contributions to the published work. This information should be listed in the manuscript under the section “Author contributions.” Examples of contributions include: designed research, performed research, analyzed data, and wrote the paper.

The corresponding author should be clearly indicated for all manuscripts submitted. A maximum of two corresponding authors are allowed for the responsibilities associated. The corresponding author(s) is/are responsible for:

  • Obtaining permission from all the authors mentioned in the manuscript in the entire editorial process, from submission to publication
  • Ensuring adherence to all editorial and submission policies and for any communications and actions that may be necessary after publication
  • Including written permission from the authors of the work concerned for any mention of any unpublished material included in the manuscript, e.g. data from manuscripts-in-press, personal communication, or work in preparation.


Conflict of Interest

At the time of submission, the authors must declare the conflicts or competing interests with any financial body or funding agency that might influence the results or interpretation of their submitted works. The disclosure should also include all sources of revenue paid (or promised to be paid) directly to authors or their institution on your behalf over the 36 months before submission of the relevant work. Authors who have nothing to declare are encouraged to add "No conflict of interest was reported by all authors" in this section.

The conflict of interest disclosure statement must be made available in cover letter and as part of the back matter at the end of a manuscript. Failure to comply with the conflict of interest disclosure statement requirement may result in rejection of the submissions.


Preprint Policy

Authors are permitted to post their non-published original research manuscripts to community preprint servers such as bioRxiv, medRxiv, and PeerJ Preprint before or in parallel with the formal submission to the CAS Medicine. During submission, authors are obliged to declare in the cover letter if the corresponding preprint version of their submission has been or will be deposited on a preprint server, and provide associated accession numbers or DOIs, if any.

Nonetheless, authors are not allowed to post any versions of articles that have been published in the journal on a preprint server. The manuscript whose corresponding preprint version has been indexed (e.g. in MEDLINE or PubMed) will not be considered, unless it is submitted to the Secondary Publications category. CAS Medicine reserves the right not to consider for publication or publish material that has been formally published in digital media that shall not be construed as preprint servers.

We encourage formal citation of preprints in the reference list, where appropriate.


Patient Anonymity and Privacy

Human subjects have a right to privacy that should not be violated without informed consent. Identifying information or patient identifiers, including patient names, initials, date of birth, contacts, medical record numbers, hospital numbers, and geographical location, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Efforts must be made by the authors to at least mask or conceal any identifying information of the patients that appear in writing or within photograph.

Authors are obliged to explain to the patient if revealing the patient’s identity cannot be fully avoided, e.g. an image of an identifiable body part like the face has to be published in the report. The relevant identifying information to be published, e.g. the image, must be shown to the patient, and consent for publication taken for the use of that information in the publication. If the patient dies, then consent must be obtained from next of kin or legal representative.


Copyright and License


The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.



International Journal of Bioprinting publishes accepted manuscripts under Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors who submit their papers for publication in CAS Medicine agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part thereof free of charge for any purpose, including commercial use. As long as the author and original source is properly cited, anyone may copy, redistribute, reuse and transform the content. 


Reuse of CAS Medicine article content

Anyone is free to reuse CAS Medicine article content licensed under CC BY 4.0 provided that proper attribution is given through citation of the original source.


Reuse of licensed material published in another journal or book (third-party content)

Authors are responsible in obtaining the appropriate permissions from the copyright owner, e.g. original publisher or authors, to reuse or republish any previously published text, figures, tables, Supplementary Information, etc., in an article of CAS Medicine licensed under a CC BY 4.0 license. The official and written proof of permission must be provided along with submission, and include in the cover letter a summary regarding the licensed materials that are reused in the paper (e.g. materials that require permission and those that do not if they were published under an unrestrictive license). Upon obtaining the permission, authors should also give proper attribution as per the copyright owner’s style.

Contact the copyright owner if you have any questions about the license terms because the Editors of CAS Medicine cannot give any legal advice regarding the rights to use third-party content. It’s the author’s responsibility to find out from the copyright owner whether it is necessary to secure permission to reuse.

Authors are not allowed to use any third-party content in the CAS Medicine paper if written permission to reuse is not obtained from the copyright owner. In the absence of official documentation granting permission to reuse third-party content or when concerns about copyright, license or permissions arise, the Editors of CAS Medicine reserves the right to remove any third-party content from any article, whether before or after publication. 


Submission Withdrawal Policy

In CAS Medicine, withdrawal of a submission refers to the removal of a new submission, a paper currently under peer-review, or an accepted paper from the online submission system. Removal of a formally published article is known as retraction.

If authors change their mind and decide not to pursue publication of papers with the journal, they must write a letter addressed to our editors at editorial@innosciencepress.com, explaining the reason(s) of submission withdrawal. Consents of all co-authors must be obtained for author-initiated submission withdrawal. The decision to withdraw a submission would eventually rest with the editors.


Advertising Policy

All advertisements are subject to approval to the Publisher. Advertisements must comply with the relevant regulations in the country where the advertisements appear. For more inquiries, please send email to editorial@innosciencepress.com.


Article Processing Charges (APC)

Article Processing Charges (APC): US$ 199 per article

Upon acceptance of any submission for publication in CAS Medicine, the editor will send an APC invoice to the corresponding author. The article will only be published following APC payment.



CAS Medicine is not liable to the statements, perspectives, and opinions contained in the published articles. The appearance of advertisements in the journal shall not be construed as a warranty, endorsement, or approval of the products or services advertised and/or the safety thereof. CAS Medicine and the Publisher disclaim responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.